Journal of Lipid Research, Vol. 9, 587-595, September 1968
Copyright © 1968 by Lipid Research, Inc.

Effect of long-term administration of AY-9944, an inhibitor of 7-dehydrocholesterol ⁷-reductase, on serum and tissue lipids in the rat

D. Dvornik and P. Hill

Department of Biochemistry, Ayerst Research Laboratories, Montreal, Canada

The effect of long-term administration of AY-9944, a specific inhibitor of cholesterol biosynthesis, was examined in rats maintained on diets with low and high cholesterol and fat content. Sterol and phospholipid levels were determined in the serum, liver, adrenals, lungs, and brain after 6 and 12 months of feeding AY-9944 at several dose levels.

In all the tissues examined, the cholesterol content was lowered and the cholesterol was partly replaced by 7-dehydrocholesterol biosynthesized instead of cholesterol in the presence of AY-9944. Cholesterol levels were particularly low in the serum and adrenals, while 7-dehydrocholesterol accumulated in the lungs. The fall in cholesterol and appearance of 7-dehydrocholesterol were reversible. Alterations of this type in the brain indicated that sterol metabolism is active in the adult rat brain. Addition of cholesterol to the diet reduced the effect of the inhibitor by eliminating the liver as a site of sterol synthesis.

Supplementary key words rat • cholesterol biosynthesis • inhibition • 7-dehydrocholesterol ⁷-reductase • cholesterol lowering • 7-dehydrocholesterol accumulation • AY-9944, chronic administration • lung • phospholipid levels • brain sterol metabolism • atherogenic diet

Submitted on January 22, 1968
Accepted on May 14, 1968

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Y. Yamashita, M. Nishibori, T. Terada, N. Isobe, and M. Shimada Gonadotropin-Induced {Delta}14-Reductase and {Delta}7-Reductase Gene Expression in Cumulus Cells during Meiotic Resumption of Porcine Oocytes Endocrinology, January 1, 2005; 146(1): 186 - 194. [Abstract] [Full Text] [PDF]

				I. Serbanescu, M. A. Ryan, R. Shukla, M. A. Cortez, O. C. Snead III, and S. C. Cunnane Lovastatin exacerbates atypical absence seizures with only minimal effects on brain sterols J. Lipid Res., November 1, 2004; 45(11): 2038 - 2043. [Abstract] [Full Text] [PDF]

				S. J. Fliesler, N. S. Peachey, M. J. Richards, B. A. Nagel, and D. K. Vaughan Retinal Degeneration in a Rodent Model of Smith-Lemli-Opitz Syndrome: Electrophysiologic, Biochemical, and Morphologic Features Arch Ophthalmol, August 1, 2004; 122(8): 1190 - 1200. [Abstract] [Full Text] [PDF]

				M. A. Cortez, C. McKerlie, and O. C. Snead III A model of atypical absence seizures: EEG, pharmacology, and developmental characterization Neurology, February 13, 2001; 56(3): 341 - 349. [Abstract] [Full Text] [PDF]

				S.-H. Bae, J. N. Lee, B. U. Fitzky, J. Seong, and Y.-K. Paik Cholesterol Biosynthesis from Lanosterol. MOLECULAR CLONING, TISSUE DISTRIBUTION, EXPRESSION, CHROMOSOMAL LOCALIZATION, AND REGULATION OF RAT 7-DEHYDROCHOLESTEROL REDUCTASE, A SMITH-LEMLI-OPITZ SYNDROME-RELATED PROTEIN J. Biol. Chem., May 21, 1999; 274(21): 14624 - 14631. [Abstract] [Full Text] [PDF]

				G S. Tint, M. Irons, E. R. Elias, A. K. Batta, R. Frieden, T. S. Chen, and G. Salen Defective Cholesterol Biosynthesis Associated with the Smith-Lemli-Opitz Syndrome N. Engl. J. Med., January 13, 1994; 330(2): 107 - 113. [Abstract] [Full Text]